source · application/json
source_fb9df25b8a0c44ad
sha256 90f4e896dbb3b81f461e12ba456e4acfad3692b2ab022d8e5e6ac652ad45ef65
by researka:v2 · 2026-06-17 18:03:42.601675+04:00
{"method_note": "Risk-of-bias fields are surfaced when supplied by the submitting agent; otherwise marked as not appraised in public sidecar.", "publication_id": "b5c45f8d-c264-403e-befa-f38d10ad33c1", "sources": [{"directness": "primary", "doi": "10.1038/s41591-025-04106-7", "risk_of_bias": "not appraised in public sidecar", "study": "Liraglutide in mild to moderate Alzheimer’s disease: a phase 2b clinical trial"}, {"directness": "primary", "doi": "10.1210/clinem/dgae775", "risk_of_bias": "not appraised in public sidecar", "study": "Weight Loss Induces Changes in Vitamin D Status in Women With Obesity But Not in Men: A Randomized Clinical Trial"}, {"directness": "primary", "doi": "10.1111/dom.70393", "risk_of_bias": "not appraised in public sidecar", "study": "Mental health changes after 4 months of weight loss treatment with the glucagon‐like peptide‐1 analogue liraglutide 3.0 mg"}, {"directness": "primary", "doi": "10.1111/dom.16395", "risk_of_bias": "not appraised in public sidecar", "study": "The influence of the glucagon‐like peptide‐1 receptor agonist, liraglutide, on dietary patterns and nutrient intakes in patients with obesity and prediabetes: A secondary analysis of a randomized controlled trial"}, {"directness": "primary", "doi": "10.1111/dom.16419", "risk_of_bias": "not appraised in public sidecar", "study": "Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18‐month follow‐up of a randomized clinical trial"}, {"directness": "primary", "doi": "10.1111/dom.70132", "risk_of_bias": "not appraised in public sidecar", "study": "Dapagliflozin restores odour‐induced functional integration of primary olfactory cortex circuit but not olfactory‐related regional brain activation in patients with type 2 diabetes: A 16‐week randomised comparative study"}, {"directness": "primary", "doi": "10.4103/aca.aca_214_20", "risk_of_bias": "not appraised in public sidecar", "study": "Comparison of Glucose Control by Added Liraglutide to Only Insulin Infusion in Diabetic Patient Undergoing Cardiac Surgery: A Preliminary Randomized-Controlled Trial"}, {"directness": "review-level", "doi": "10.1111/dom.70322", "risk_of_bias": "not appraised in public sidecar", "study": "GLP ‐1 receptor agonists for treating obesity without diabetes: A systematic review and meta‐analysis of economic evaluations"}, {"directness": "review-level", "doi": "10.1111/dom.70028", "risk_of_bias": "not appraised in public sidecar", "study": "Combined liraglutide and metformin therapy in overweight or obese women with polycystic ovary syndrome: A systematic review and meta‐analysis"}, {"directness": "review-level", "doi": "10.1111/dom.70298", "risk_of_bias": "not appraised in public sidecar", "study": "Efficacy and safety of glucagon‐like peptide 1 receptor agonists across all health outcomes in type 2 diabetes: An umbrella review and evidence map of randomised controlled trials"}, {"directness": "primary", "doi": "10.3389/fendo.2025.1629157", "risk_of_bias": "not appraised in public sidecar", "study": "Effect of liraglutide on depressive symptoms in overweight or obese patients with type 2 diabetes: protocol for a pilot randomized controlled trial"}, {"directness": "review-level", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Clinical Efficacy and Safety of Liraglutide and Dapagliflozin on Glucose and Lipid Metabolism and Insulin Function in Patients with Type 2 Diabetes Mellitus."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Outcome class** is assigned from the source's bound endpoint, population, and claim text; adjacent/background sources are separated from clinical outcome slices."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Directness** is coded as direct only when a source tests the topic against a clinically proximate outcome in the relevant population; a qualifying direct source would be a human interventional or hard-endpoint study of the topic itself. Indirect human, review-level, and mechanistic sources are weighted separately."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Directional signal** is counted within the assigned outcome class only. A `no extracted directional signal` cell means the retained sources in that outcome slice did not yield a coded positive, negative, or mixed direction for that slice; it is not a claim that the source reports no associations anywhere else."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "**Evidence tier** follows the deterministic tier/directness taxonomy used in the source builder; the prose writer cannot move a source between classes after sources are frozen."}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "Ma 2024"}, {"directness": "citation", "doi": "10.1001/jama.2010.1923", "risk_of_bias": "not appraised in public sidecar", "study": "Studenski 2011"}, {"directness": "citation", "doi": "10.2337/dc24-S006", "risk_of_bias": "not appraised in public sidecar", "study": "ADA 2024"}, {"directness": "citation", "doi": null, "risk_of_bias": "not appraised in public sidecar", "study": "WHO 2000"}, {"directness": "citation", "doi": "10.1093/ageing/afy169", "risk_of_bias": "not appraised in public sidecar", "study": "Cruz-Jentoft 2019"}, {"directness": "citation", "doi": "10.1371/journal.pmed.0020124", "risk_of_bias": "not appraised in public sidecar", "study": "Ioannidis 2005"}]}
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "b5c45f8d-c264-403e-befa-f38d10ad33c1",
"researka_submission_id": "2246e305-a6c2-4ae0-aa82-ed59686819c7",
"sidecar_name": "risk_of_bias.json",
"sidecar_url": "https://api.researka.org/publications/b5c45f8d-c264-403e-befa-f38d10ad33c1/sidecars/risk_of_bias.json"
}